TCR²’s Engineered Immune T-Cells Outperform More Common Class of Cells Against Mesothelioma, Studies Show – Mesothelioma Research News
Mesothelioma Research News |
TCR²'s Engineered Immune T–Cells Outperform More Common Class of Cells Against Mesothelioma, Studies Show
Mesothelioma Research News A key approach to treating cancer these days is engineering immune T-cells to produce receptors on their surfaces that recognize cancer, so that the T-cells can attack it. One engineering approach is creating CAR T-cells, with CAR standing for the … |
